Receptor Mediated Delivery of Cas9-Nanobody Induces Cisplatin Synthetic Dose Sensitivity
Philip J. R Roche, Heidi Gytz, Faiz Hussain, Yingke Liang, Nick Stub Laursen, Kasper R. Andersen, Bhushan Nagar, Uri David Akavia
This study demonstrates receptor-mediated delivery of Cas9-Nanobody to A549 cells, enhancing cisplatin sensitivity through synthetic dose lethality.
bioRxiv · Aug 9, 2018 · PreprintBiochemistry